German drug maker Merck KGaA (MKGAY.PK) Thursday boosted its forecast for the full year, citing good operational performance and the acquisition of Sigma-Aldrich. The company also reported increased profit for the third quarter, as sales improved with the Life Science business driving organic sales growth of the Group.